Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

Sadly Odidi has turned all the potential here into failure and single-handedly destroyed the valuation metrics still in play here for at least another full calendar year minimum...and I honestly don't see IPCI having another full calendar year to start vastly improving the valuation metrics still in play.

We know they have lawsuit battle coming in 2 months with Purdue...and we know they hope to resubmit Rexista by end of year.

But beyond that it's becoming apparent that neither Pristiq or Lamictal will get FDA approved by EOY so those 2 ANDA's will most likely go the same way Glucophage and Keppra do if/when the FDA ever does get around to approving them.

So beyond Rexista maybe getting in front of another AdCom next summer what else is there in IPCI's beyond stagnant/failed pipeline to even get excited about anymore?

5 years ago there was real potential in play here...but lack of FDA approvals and relevant progress has basically destroyed all of it...and the countdown to fresh dilution has begun in the post reverse split era.

If Odidiot does a 1:15 ratio from .25 cent level that only gives him a post reverse split starting point level of 3.75, the level it was almost trading at prior to last summers disastrous Rexista Adcom lol.